# Safety and Efficacy Study of HuCNS-SC in Subjects With Neuronal Ceroid Lipofuscinosis

> **NCT01238315** · PHASE1 · WITHDRAWN · sponsor: **StemCells, Inc.**

## Conditions studied

- Neuronal Ceroid Lipofuscinosis

## Interventions

- **BIOLOGICAL:** HuCNS-SC

## Key facts

- **NCT ID:** NCT01238315
- **Lead sponsor:** StemCells, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-11
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of timely patient accrual
- **Last updated:** 2015-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01238315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01238315, "Safety and Efficacy Study of HuCNS-SC in Subjects With Neuronal Ceroid Lipofuscinosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01238315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*